Search

Search Constraints

You searched for: Author/Creator Knopman, David S.

Search Results

411. Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures. (16th July 2019)

412. Plasma Biomarkers of Amyloid and Neurodegeneration predictive of Neuropathologic Scales of Cerebrovascular Disease. (20th December 2022)

413. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. (4th May 2021)

414. Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC‐NCS). Issue 1 (6th May 2016)

415. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography. Issue 8 (4th April 2018)

417. Popular MRI de‐facing software does not sufficiently protect participants from re‐identification via face recognition: Neuroimaging / Optimal neuroimaging measures for tracking disease progression. (7th December 2020)

419. Potential for Re‐Identifying Brain PET Research Participants using Face Recognition. (20th December 2022)

420. Potential for Re‐Identifying Brain PET Research Participants using Face Recognition. (20th December 2022)